Literature DB >> 15728592

Direct detection of angioinvasive pulmonary aspergillosis in immunosuppressed patients: preliminary results with high-resolution 16-MDCT angiography.

Stefan Sonnet1, Carlos Hernando Buitrago-Téllez, Michael Tamm, Susanne Christen, Wolfgang Steinbrich.   

Abstract

OBJECTIVE: The aim of this study was to optimize detection of angioinvasive pulmonary aspergillosis by showing direct vessel involvement at a peripheral level with high-resolution MDCT angiography in patients with antibiotic-resistant fever of unknown origin under immunosuppression. Twelve CT angiographic examinations were prospectively performed in 10 patients with an optimized CT angiography protocol with 16-MDCT after IV administration of contrast agent using care bolus (Siemens Medical Solutions). Axial images and maximum intensity projections were evaluated for vascular occlusion by an experienced radiologist blinded to the clinical histories. Results were correlated with histology and clinical follow-up data including follow-up CT. Fourteen focal pulmonary lesions were detected by CT in eight patients. Eight of 14 lesions were confirmed by histology. In the remaining six lesions, diagnosis was made by clinical and CT follow-up. In nine of nine lesions in which angioinvasive infection was excluded, CT angiography showed patent vessels. In four of five lesions with histologically proven fungal angioinvasion, vascular occlusion was detected on CT angiography.
CONCLUSION: High-resolution MDCT angiography has been shown to be a feasible technique to depict directly vessel occlusion in the setting of suspected fungal infections, especially for early diagnosis of angioinvasive pulmonary aspergillosis in immunosuppressed patients.

Entities:  

Mesh:

Year:  2005        PMID: 15728592     DOI: 10.2214/ajr.184.3.01840746

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  7 in total

1.  The utility of contrast-enhanced hypodense sign for the diagnosis of pulmonary invasive mould disease in patients with haematological malignancies.

Authors:  Claudia Sassi; Marta Stanzani; Russell E Lewis; Giancarlo Facchini; Alberto Bazzocchi; Michele Cavo; Giuseppe Battista
Journal:  Br J Radiol       Date:  2018-01-10       Impact factor: 3.039

2.  Successful management of invasive pulmonary nocardiosis and aspergillosis in a patient with T-cell lymphoma: a case report.

Authors:  Khalid A Al-Anazi; Mahmoud D Aljurf; Fahad I Al-Mohareb; Laila Al-Dabal; Mohammed Zaitoni; Majed Halim
Journal:  Clin Med Case Rep       Date:  2008-05-27

3.  Diagnostic Performance of Contrast Enhanced Pulmonary Computed Tomography Angiography for the Detection of Angioinvasive Pulmonary Aspergillosis in Immunocompromised Patients.

Authors:  C Henzler; T Henzler; D Buchheidt; John W Nance; C A Weis; R Vogelmann; U Benck; T Viergutz; T Becher; T Boch; S A Klein; D Heidenreich; L Pilz; M Meyer; P M Deckert; W-K Hofmann; S O Schoenberg; M Reinwald
Journal:  Sci Rep       Date:  2017-06-30       Impact factor: 4.379

Review 4.  Practice Guidelines for the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis in an Intensive Care Setting.

Authors:  Zia Hashim; Zafar Neyaz; Rungmei S K Marak; Alok Nath; Soniya Nityanand; Naresh K Tripathy
Journal:  J Intensive Care Med       Date:  2021-10-22       Impact factor: 2.889

Review 5.  Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients.

Authors:  Georg Maschmeyer; Antje Haas; Oliver A Cornely
Journal:  Drugs       Date:  2007       Impact factor: 11.431

6.  The role of multidetector computed tomography in the early diagnosis of invasive pulmonary aspergillosis in patients with febrile neutropenia undergoing hematopoietic stem cell transplantation.

Authors:  Nazan Ciledağ; Kemal Arda; Bilgin Kadri Arıbaş; Ali Irfan Emre Tekgündüz; Fevzi Altuntaş
Journal:  Turk J Haematol       Date:  2012-03-05       Impact factor: 1.831

7.  Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Authors:  G Maschmeyer; J Carratalà; D Buchheidt; A Hamprecht; C P Heussel; C Kahl; J Lorenz; S Neumann; C Rieger; M Ruhnke; H Salwender; M Schmidt-Hieber; E Azoulay
Journal:  Ann Oncol       Date:  2014-05-15       Impact factor: 32.976

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.